GlobalData
GlobalData

Kristian Jackson

  • Home
  • Author: Kristian Jackson

Competition in Multiple Sclerosis market set to increase with launch of new pipeline drugs and entry of new generics

The Multiple Sclerosis (MS) therapeutics market has entered an exciting phase, with an upsurge of available treatment options and several promising late-stage pipeline products offering diverse mechanisms of action (MOAs). The launch of 12 new therapies will drive growth in the MS space, provide more options for patients, and stimulate further competition, says GlobalData, a leading data and analytics company.
Read more
1 2 3 13